Immune Tolerance Network
Carolyn Bromstead is an experienced clinical operations professional with a robust background in clinical research and management. Currently serving as a Clinical Operations Manager at the Immune Tolerance Network since November 2020, Carolyn has previously held similar managerial roles at the organization from 2002 to 2007 and has contributed as a Clinical Research Coordinator at Pacific Research Partners from 2018 to 2020. Experience also includes positions as Clinical Research Contractor and Clinical Research Associate at Immune Tolerance Network and Elan Pharmaceuticals, along with roles at Inveresk Research, Quintiles, and Commonwealth Research Center at Harvard Medical School. Carolyn holds a Bachelor of Arts degree in Psychology from Cornell University, earned in 1992.
Immune Tolerance Network
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.